Brad Knott sold Oramed Pharmaceuticals Inc (NASDAQ: ORMP)
Brad Knott (R-NC), a U.S. Representative, has disclosed 1 trade in Oramed Pharmaceuticals Inc (ORMP) since 2025, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Brad Knott sold $15,001 - $50,000 of Oramed Pharmaceuticals Inc (NASDAQ: ORMP) on January 10, 2025. Since that trade, ORMP is up +79.53% against the S&P 500 up +31.40%, an outperformance of +48.13%.
Data updated
Brad Knott's ORMP trades vs the price
ORMP is up +79.53% since Brad Knott sold on January 10, 2025, versus +31.40% for the S&P 500.
Performance since this trade
All Brad Knott ORMP trades
Brad Knott & ORMP trading FAQ
Is it legal for Brad Knott to trade Oramed Pharmaceuticals Inc (ORMP) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Oramed Pharmaceuticals Inc (ORMP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Brad Knott sell ORMP?
Brad Knott disclosed a sale of $15,001 - $50,000 of Oramed Pharmaceuticals Inc (ORMP) on January 10, 2025, according to public STOCK Act filings.
How has ORMP performed since Brad Knott's trade?
Since Brad Knott sold ORMP on January 10, 2025, the stock is up +79.53%, versus +31.40% for the S&P 500 over the same period, an outperformance of +48.13%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ORMP trades?
Quantellect tracks every disclosed congressional trade in Oramed Pharmaceuticals Inc (ORMP) on the Oramed Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Brad Knott's ORMP tradesAll congressional filings for Oramed Pharmaceuticals IncBrad Knott's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.